NextGeM develops cutting-edge creative technologies and provides innovative products and services by combining hematopoietic stem cell technologies and digital technologies such as AI and machine learning
NextGeM consists of professionals from academics, healthcare providers, business professionals and entrepreneurs, and starts the business to provide solutions to the clinical problems by using the next generation bio-digital technology. We develop the world’s most advanced products by leveraging cutting-edge technologies and talented professionals.
novel value creation utilizing bio and digital technology
Business concept is to address clinical problems and tackle more difficult challenges by integrating bio and digital technologies.
Focus area utilizing bio and digital technology
Our proprietary technologies will add value at all stages throughout the patient journey including “prevention”, “diagnosis” and “treatment”.
Digital technologies such as AI are mainly used for prevention and diagnosis, while biotechnologies of hematopoietic stem cells are mainly used for diagnosis and treatment.
NexGeM not only provides its own medical solutions, but aims to commercialize the technological seeds from academia and other companies by combining with our technologies.
we also assist in commercializing (strategy planning and execution) technological seeds with our team members’ expertise together with our proven track record for commercialization.
